Skip to content
value.today

Sift Medical Data, Inc.

Total raised
$27 M
2 rounds on record
Latest round
$20 M
Apr 2024
First round on record
Jul 2022
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Sift Medical Data, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2024$20 MNo. 2$10 to $50 million

Sift Medical Data, Inc.: Raise no. 2, Apr 2024

Investors in this round

19 investors had bought by the notice of May 14, 2024: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
$4,967
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$1,350,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Wisconsin

People named in the notice

  • Justin Nicols · Executive Officer, Director · Chief Executive Officer and Director
  • Robert Hoyler · Executive Officer · Chief Operating Officer
  • Adam Seabrook · Director
  • Jefferson DeAngelis · Director
  • Jonathan Phillips · Director
  • Kurt Brenkus · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Response reflects the estimated amount the proceeds to be used as compensation for executive officers during the next 12 months.”

Signed by Robert C. Hoyler, Chief Operating Officer. Source: SEC Form D, newest notice filed May 14, 2024. Read the notice at the SEC.

equitySEC
Jul 2022$7 MNo. 1$2 to $10 million

Sift Medical Data, Inc.: Raise no. 1, Jul 2022

Investors in this round

13 investors had bought by the notice of Mar 24, 2023: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$400,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Wisconsin

People named in the notice

  • Justin Nicols · Executive Officer, Director
  • Kenneth Cunningham · Executive Officer
  • Robert Hoyler · Executive Officer
  • Arvind Subramanian · Director · Former Director as of July 11, 2022
  • Jefferson DeAngelis · Director
  • Kurt Brenkus · Director
  • Marc Kiven · Director · Former Director as of July 11, 2022
  • McIlwraith John · Director · Elected Director as of July 11, 2022

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert C. Hoyler, Chief Operating Officer. Source: SEC Form D and 1 amendment, newest notice filed Mar 24, 2023. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Sift Medical Data, Inc. had revenue between $1 million and $5 million when it filed its newest notice of a funding round (May 2024).

    SEC Form D (revenue range) · May 2024

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · May 2024

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Sift Medical Data, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 19 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Sift Medical Data, Inc.
NameRoleNamed in
Justin NicolsChief Executive Officer and DirectorMay 2024
Robert HoylerChief Operating OfficerMay 2024
Kenneth CunninghamExecutive officerMar 2023
Adam SeabrookDirectorMay 2024
Jefferson DeAngelisDirectorMay 2024
Jonathan PhillipsDirectorMay 2024
Justin NicolsChief Executive Officer and DirectorMay 2024
Kurt BrenkusDirectorMay 2024
Arvind SubramanianFormer Director as of July 11, 2022Mar 2023
Marc KivenFormer Director as of July 11, 2022Mar 2023
McIlwraith JohnElected Director as of July 11, 2022Mar 2023